News | Robotic Systems | October 25, 2016

New Jersey Physician Surpasses 500 Procedures Using Stereotaxis Niobe System

Physicians at Robert Wood Johnson University Hospital have used remote magnetic navigation system in more than 1,500 procedures to date, the most of any hospital in North America

Niobe remote magnetic navigation system, cardiac abltion, Robert Wood Johnson University Hospital, New Jersey, 500 procedures

October 25, 2016 — Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed more than 500 cardiac ablation procedures using the Niobe remote magnetic navigation system. Younan currently leads the Northeast region in catheter ablations performed using the Niobe system in the six-and-a-half years since installation.

RWJUH, a Cardiovascular Center of Excellence and the principal teaching hospital of the Rutgers Robert Wood Johnson Medical School in New Brunswick, N.J. first installed the Niobe system in 2010 and upgraded to the Niobe ES system in early 2012. Since that time, the electrophysiology lab has increased its patient caseload, through shorter procedure times, and by attracting more patients with a wide range of complex heart arrhythmias. 

Collectively, the physicians of RWJUH have utilized Stereotaxis remote magnetic navigation technology in more than 1,500 procedures to date, more than any other hospital in North America from 2010 to present.

“Stereotaxis technologies are amazing innovations, and the contrasts with traditional methods are striking,” said Younan. “With the remote magnetic navigation and detailed mapping tools of the Niobe system, we are able to navigate the ablation catheter more quickly, safely, and precisely — even in hard-to-reach regions of the heart. As a result, we see decreased radiation exposure, lower risk of complications and higher success rates, particularly for challenging procedures such as ventricular tachycardia. I believe this system will eventually become the gold standard in cardiac ablations.”    

“Stereotaxis provides yet another advanced treatment approach that is available to cardiac patients at RWJUH,” said Michael Antoniades, President and CEO of Robert Wood Johnson University Hospital.  “Our team has a well-earned reputation for expanding the boundaries of medicine while delivering cutting-edge, quality care to patients.”

For more information: www.stereotaxis.com


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now